We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Study Finds Commercially Available Antibodies Are Not Binding Their Target

News   Oct 16, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
Study Finds Commercially Available Antibodies Are Not Binding Their Target

A new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly. Credit: The Neuro.

 
 
 

RELATED ARTICLES

A Potential New Way to Diagnose Male Infertility

News

Infertile men have identifiable patterns of epigenetic molecules or biomarkers attached to their sperm DNA that aren’t present in fertile men. These findings could eventually provide doctors with a reliable method of screening men for infertility and figuring out which treatment options will work best for their patients.

READ MORE

Lithium Reverses Radiation Damage After Brain Tumor Treatment

News

Research in mice has shown that the drug lithium can be used to reverse radiation damage from the treatment of brain tumors.

READ MORE

Clinical Trial To Target Proteins in the Gut To Slow Down Parkinson's

News

Scientists are aiming to target the gut with a compound that can inhibit the aggregation of alpha-synuclein, in the hopes they may be able to slow the progression of Parkinson's disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Diagnostics Genomics Research Proteomics & Metabolomics Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE